Prasinezumab Uses, Dosage, Side Effects and more
Prasinezumab is under investigation in clinical trial NCT03100149 (A Study to Evaluate the Efficacy of Prasinezumab (RO7046015/PRX002) in Participants With Early Parkinson's Disease).
| Attribute | Details |
|---|---|
| Trade Name | Prasinezumab |
| Generic | Prasinezumab |
| Prasinezumab Other Names | Prasinezumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
